300 related articles for article (PubMed ID: 33843684)
1. Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
Norins LC
J Alzheimers Dis; 2021; 81(3):921-932. PubMed ID: 33843684
[TBL] [Abstract][Full Text] [Related]
2. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
3. Medical genetics-based drug repurposing for Alzheimer's disease.
Zhang XZ; Quan Y; Tang GY
Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
[TBL] [Abstract][Full Text] [Related]
4. Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs.
Ihara M; Saito S
J Alzheimers Dis; 2020; 74(4):1013-1028. PubMed ID: 32144994
[TBL] [Abstract][Full Text] [Related]
5. Drug repositioning in Alzheimer's disease.
Corbett A; Williams G; Ballard C
Front Biosci (Schol Ed); 2015 Jun; 7(1):184-8. PubMed ID: 25961694
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
7. Approved drugs are to be studied for use in Alzheimer's disease.
Hopkins Tanne J
BMJ; 2016 Sep; 354():i5063. PubMed ID: 27644990
[No Abstract] [Full Text] [Related]
8. Machine learning identifies candidates for drug repurposing in Alzheimer's disease.
Rodriguez S; Hug C; Todorov P; Moret N; Boswell SA; Evans K; Zhou G; Johnson NT; Hyman BT; Sorger PK; Albers MW; Sokolov A
Nat Commun; 2021 Feb; 12(1):1033. PubMed ID: 33589615
[TBL] [Abstract][Full Text] [Related]
9. Repurposed agents in the Alzheimer's disease drug development pipeline.
Bauzon J; Lee G; Cummings J
Alzheimers Res Ther; 2020 Aug; 12(1):98. PubMed ID: 32807237
[TBL] [Abstract][Full Text] [Related]
10. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
11. Toward an early diagnosis and treatment of Alzheimer's disease.
Nordberg A
Int Psychogeriatr; 2003 Sep; 15(3):223-37. PubMed ID: 14756159
[TBL] [Abstract][Full Text] [Related]
12. The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease.
Cappell J; Herrmann N; Cornish S; Lanctôt KL
CNS Drugs; 2010 Nov; 24(11):909-27. PubMed ID: 20932064
[TBL] [Abstract][Full Text] [Related]
13. Old Drugs with New Tricks: Paradigm in Drug Development Pipeline for Alzheimer's Disease.
Dalvi T; Dewangan B; Das R; Rani J; Shinde SD; Vhora N; Jain A; Sahu B
Cent Nerv Syst Agents Med Chem; 2020; 20(3):157-176. PubMed ID: 33087034
[TBL] [Abstract][Full Text] [Related]
14. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
15. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Kumar S; Chowdhury S; Kumar S
BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
[TBL] [Abstract][Full Text] [Related]
16. [Drug Repositioning for Alzheimer's Disease].
Ihara M; Saito S
Brain Nerve; 2019 Sep; 71(9):961-970. PubMed ID: 31506398
[TBL] [Abstract][Full Text] [Related]
17. DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
Jones R; Sheehan B; Phillips P; Juszczak E; Adams J; Baldwin A; Ballard C; Banerjee S; Barber B; Bentham P; Brown R; Burns A; Dening T; Findlay D; Gray R; Griffin M; Holmes C; Hughes A; Jacoby R; Johnson T; Jones R; Knapp M; Lindesay J; McKeith I; McShane R; Macharouthu A; O'Brien J; Onions C; Passmore P; Raftery J; Ritchie C; Howard R;
Trials; 2009 Jul; 10():57. PubMed ID: 19630974
[TBL] [Abstract][Full Text] [Related]
18. Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease.
Li C; Ebrahimi A; Schluesener H
Ageing Res Rev; 2013 Jan; 12(1):116-40. PubMed ID: 22982398
[TBL] [Abstract][Full Text] [Related]
19. Discovering new treatments for Alzheimer's disease by repurposing approved medications.
Appleby BS; Cummings JL
Curr Top Med Chem; 2013; 13(18):2306-27. PubMed ID: 24059463
[TBL] [Abstract][Full Text] [Related]
20. Repurposing Antihypertensive Drugs for the Management of Alzheimer's Disease.
Law CSW; Yeong KY
Curr Med Chem; 2021; 28(9):1716-1730. PubMed ID: 32164502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
